Comparators in the assessment On the basis of the alternatives presented, identify the technologies to be used as comparator(s) for the assessment. Comparators can differ from the technology in their mechanism of action (whether physical, chemical or mechanical). If the comparators are different from the technologies identified as alternatives to the intervention or the technologies to which the intervention will be added, provide a justification for the differences. [add details here] Current use of the technology Summary of issues relating to current use of the technology In no more than 6 bullet points describe key statements about the current use of the technology. For example, include statements about the availability and reimbursement status of the technology in other countries, the populations in which the technology is currently used (if available). key statement key statement key statement key statement key statement key statement Current use of the technology Complete only if the technology is available in one or more European countries. Describe the experience of using the technology, for example the health conditions and populations, and the purposes for which the technology is currently used. Include whether the current use of the technology differs from that described in the (expected) authorisation. [add details here]
Comparators in the assessment On the basis of the alternatives presented, identify the technologies to be used as comparator(s) for the assessment. Comparators can differ from the technology in their mechanism of action (whether physical, chemical or mechanical). If the comparators are different from the technologies identified as alternatives to the intervention or the technologies to which the intervention will be added, provide a justification for the differences. [add details here] Current use of the technology Summary of issues relating to current use of the technology In no more than 6 bullet points describe key statements about the current use of the technology. For example, include statements about the availability and reimbursement status of the technology in other countries, the populations in which the technology is currently used (if available). key statement key statement key statement key statement key statement key statement Current use of the technology Complete only if the technology is available in one or more European countries. Describe the experience of using the technology, for example the health conditions and populations, and the purposes for which the technology is currently used. Include whether the current use of the technology differs from that described in the (expected) authorisation. [add details here]
EUnetHTA%20evidence%20submission%20template%20for%20pharmaceuticals%20short%20form.docx